Stanford doctors have developed an innovative left ventricular decompression vent with multiple-channels design that significantly enhances blood removal during cardiac surgery.
Researchers at Stanford University have created a novel mitral valve annuloplasty ring that can be adjusted in size off-bypass in response to regurgitation.
Stanford researchers have invented a twist-expand mechanical bioreactor that provides an appropriate in vitro microenvironment for induced pluripotent stem cell (iPSC) derived cardiomyocytes to achieve biomimetic anisotropic alignment and form contractile cardiac tissue
Stanford researchers in the Woo Lab have developed a modular bioprosthetic valve that allows for customizable leaflet configurations, ranging from bi- to multi-leaflet designs.
Stanford researchers in the Woo Lab have designed an implantable prosthetic for patients with aortic valve dysfunction, particularly for use in valve-sparing aortic root replacement procedures.
Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.
Stanford researchers at the Woo Lab have designed and manufactured a flexible, compact laparoscopic device for knot tying during cardiac, thoracic, and ENT operations.
Stanford researchers at the Woo Lab have invented a composite inclusion graft that addresses several challenges associated with the Ross procedure, such as late autograft dilation.
Stanford researchers at the Woo Lab have developed an innovative supra-hemostasis aortic graft, an advanced version of conventional aortic grafts. Current aortic grafts do not have reinforced suture area which can cause bleeding around the anastomosis line.
Stanford researchers at the Woo Lab have designed an innovative prosthetic valve to address challenges in mitral valve replacement for patients with severe mitral annular calcification (MAC).
Stanford scientists developed a comprehensive, minimally invasive, dual-catheter pulsed field device that utilizes a rapid and simple integrated mapping/ablation strategy for the treatment of Atrial Fibrillation.